384 related articles for article (PubMed ID: 34337081)
1. A Novel Insight into the Role of PLA2R and THSD7A in Membranous Nephropathy.
Zhang P; Huang W; Zheng Q; Tang J; Dong Z; Jiang Y; Liu Y; Liu W
J Immunol Res; 2021; 2021():8163298. PubMed ID: 34337081
[TBL] [Abstract][Full Text] [Related]
2. PLA2R and THSD7A: Disparate Paths to the Same Disease?
Beck LH
J Am Soc Nephrol; 2017 Sep; 28(9):2579-2589. PubMed ID: 28674044
[TBL] [Abstract][Full Text] [Related]
3. Antigen-Specific IgG Subclasses in Primary and Malignancy-Associated Membranous Nephropathy.
von Haxthausen F; Reinhard L; Pinnschmidt HO; Rink M; Soave A; Hoxha E; Stahl RAK
Front Immunol; 2018; 9():3035. PubMed ID: 30619370
[TBL] [Abstract][Full Text] [Related]
4. Autoantibodies against thrombospondin type 1 domain-containing 7A induce membranous nephropathy.
Tomas NM; Hoxha E; Reinicke AT; Fester L; Helmchen U; Gerth J; Bachmann F; Budde K; Koch-Nolte F; Zahner G; Rune G; Lambeau G; Meyer-Schwesinger C; Stahl RA
J Clin Invest; 2016 Jul; 126(7):2519-32. PubMed ID: 27214550
[TBL] [Abstract][Full Text] [Related]
5. Circulating Antibodies against Thrombospondin Type-I Domain-Containing 7A in Chinese Patients with Idiopathic Membranous Nephropathy.
Wang J; Cui Z; Lu J; Probst C; Zhang YM; Wang X; Qu Z; Wang F; Meng LQ; Cheng XY; Liu G; Debiec H; Ronco P; Zhao MH
Clin J Am Soc Nephrol; 2017 Oct; 12(10):1642-1651. PubMed ID: 28801527
[TBL] [Abstract][Full Text] [Related]
6. Circulating antibodies against M-type phospholipase A2 receptor and thrombospondin type-1 domain-containing 7A in Chinese patients with membranous nephropathy.
Tian C; Li L; Liu T; Qu X; Qiu Y
Int Urol Nephrol; 2019 Aug; 51(8):1371-1377. PubMed ID: 31227982
[TBL] [Abstract][Full Text] [Related]
7. Molecular classification of membranous nephropathy.
Pozdzik A; Touzani F; Brochériou I; Corazza F
Curr Opin Nephrol Hypertens; 2019 Jul; 28(4):336-344. PubMed ID: 31045661
[TBL] [Abstract][Full Text] [Related]
8. The Prevalence, Characteristics, and Putative Mechanisms of Dual Antigen-Positive Membranous Nephropathy: The Underestimated Condition.
Uchida T; Oda T
Int J Mol Sci; 2024 May; 25(11):. PubMed ID: 38892120
[TBL] [Abstract][Full Text] [Related]
9. Autoantigens PLA2R and THSD7A in membranous nephropathy share a common epitope motif in the N-terminal domain.
Fresquet M; Rhoden SJ; Jowitt TA; McKenzie EA; Roberts I; Lennon R; Brenchley PE
J Autoimmun; 2020 Jan; 106():102308. PubMed ID: 31395435
[TBL] [Abstract][Full Text] [Related]
10. Clinical and Histological Features of Phospholipase A2 Receptor-Associated and Thrombospondin Type-I Domain-containing 7A-Associated Idiopathic Membranous Nephropathy: A Single Center Retrospective Study from China.
Zhang D; Zou J; Zhang C; Zhang W; Lin F; Jiang G
Med Sci Monit; 2018 Jul; 24():5076-5083. PubMed ID: 30032157
[TBL] [Abstract][Full Text] [Related]
11. Thrombospondin type-1 domain-containing 7A in idiopathic membranous nephropathy.
Tomas NM; Beck LH; Meyer-Schwesinger C; Seitz-Polski B; Ma H; Zahner G; Dolla G; Hoxha E; Helmchen U; Dabert-Gay AS; Debayle D; Merchant M; Klein J; Salant DJ; Stahl RAK; Lambeau G
N Engl J Med; 2014 Dec; 371(24):2277-2287. PubMed ID: 25394321
[TBL] [Abstract][Full Text] [Related]
12. Membranous Nephropathy and Anti-Podocytes Antibodies: Implications for the Diagnostic Workup and Disease Management.
Pozdzik A; Brochériou I; David C; Touzani F; Goujon JM; Wissing KM
Biomed Res Int; 2018; 2018():6281054. PubMed ID: 29511687
[TBL] [Abstract][Full Text] [Related]
13. THSD7A staining of membranous glomerulopathy in clinical practice reveals cases with dual autoantibody positivity.
Larsen CP; Cossey LN; Beck LH
Mod Pathol; 2016 Apr; 29(4):421-6. PubMed ID: 26847174
[TBL] [Abstract][Full Text] [Related]
14. Features of phospholipase A2 receptor and thrombospondin type-1 domain-containing 7A in malignancy-associated membranous nephropathy.
Zhang C; Zhang M; Chen D; Ren Q; Xu W; Zeng C; Qin W; Liu Z
J Clin Pathol; 2019 Oct; 72(10):705-711. PubMed ID: 31243053
[TBL] [Abstract][Full Text] [Related]
15. An update on clinical significance of use of THSD7A in diagnosing idiopathic membranous nephropathy: a systematic review and meta-analysis of THSD7A in IMN.
Ren S; Wu C; Zhang Y; Wang AY; Li G; Wang L; Hong D
Ren Fail; 2018 Nov; 40(1):306-313. PubMed ID: 29623759
[TBL] [Abstract][Full Text] [Related]
16. Membranous nephropathy-one morphologic pattern with different diseases.
Hoxha E; von Haxthausen F; Wiech T; Stahl RAK
Pflugers Arch; 2017 Aug; 469(7-8):989-996. PubMed ID: 28555350
[TBL] [Abstract][Full Text] [Related]
17. Mechanisms of Primary Membranous Nephropathy.
Gu Y; Xu H; Tang D
Biomolecules; 2021 Mar; 11(4):. PubMed ID: 33808418
[TBL] [Abstract][Full Text] [Related]
18. Identification of the immunodominant epitope region in phospholipase A2 receptor-mediating autoantibody binding in idiopathic membranous nephropathy.
Kao L; Lam V; Waldman M; Glassock RJ; Zhu Q
J Am Soc Nephrol; 2015 Feb; 26(2):291-301. PubMed ID: 25205735
[TBL] [Abstract][Full Text] [Related]
19. Characterization of autoantibodies in primary membranous nephropathy and their clinical significance.
Stahl RA; Reinhard L; Hoxha E
Expert Rev Clin Immunol; 2019 Feb; 15(2):165-175. PubMed ID: 30433832
[No Abstract] [Full Text] [Related]
20. Membranous nephropathy: integrating basic science into improved clinical management.
Cattran DC; Brenchley PE
Kidney Int; 2017 Mar; 91(3):566-574. PubMed ID: 28065518
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]